Stocks Overview

LAST PRICE
2.1895
TODAY'S CHANGE (%)
Trending Down-0.1105 (-4.8043%)

Bid / Lots
2.1800/ 142
Ask / Lots
2.1900/ 5
Open / Previous Close
2.4200 / 2.3000
Day Range
Low 2.1895
High 2.4200
52 Week Range
Low 0.6610
High 3.1200
Volume
265,718
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Monday's close: 2.3
Time	Volume	CRDL
09:32 ET	6043	2.35
09:36 ET	2564	2.33
09:38 ET	5400	2.3446
09:39 ET	1332	2.31
09:43 ET	8097	2.32
09:45 ET	7006	2.3
09:48 ET	11000	2.31
09:52 ET	100	2.32
10:01 ET	1800	2.29
10:03 ET	5995	2.28
10:06 ET	10000	2.27
10:08 ET	100	2.275
10:10 ET	450	2.265
10:14 ET	600	2.2697
10:15 ET	550	2.265
10:17 ET	5026	2.2892
10:24 ET	100	2.27
10:26 ET	2600	2.255
10:28 ET	1800	2.265
10:30 ET	500	2.261
10:32 ET	300	2.25
10:33 ET	6366	2.22
10:35 ET	400	2.23
10:37 ET	7395	2.225
10:39 ET	200	2.22
10:44 ET	200	2.2289
10:50 ET	350	2.24
10:51 ET	400	2.235
10:53 ET	201	2.235
10:57 ET	2117	2.23
11:00 ET	5400	2.2299
11:08 ET	250	2.225
11:09 ET	3716	2.23
11:13 ET	12376	2.22
11:18 ET	883	2.2199
11:20 ET	400	2.21
11:22 ET	100	2.21
11:24 ET	200	2.21
11:26 ET	4184	2.2
11:27 ET	24170	2.2
11:29 ET	742	2.215
11:31 ET	500	2.21
11:33 ET	4236	2.23
11:36 ET	600	2.24
11:38 ET	800	2.235
11:44 ET	1700	2.215
11:47 ET	614	2.21
11:51 ET	150	2.21
11:54 ET	5000	2.215
11:56 ET	300	2.22
12:00 ET	1100	2.205
12:02 ET	200	2.2099
12:09 ET	225	2.21
12:16 ET	24000	2.2
12:18 ET	1000	2.21
12:21 ET	2120	2.23
12:32 ET	1800	2.215
12:36 ET	27874	2.22
12:38 ET	2000	2.215
12:52 ET	500	2.2195
01:12 ET	2900	2.215
01:14 ET	100	2.215
01:28 ET	300	2.215
01:37 ET	2713	2.22
01:39 ET	5400	2.225
01:46 ET	751	2.215
01:48 ET	3699	2.206
01:55 ET	600	2.2
01:57 ET	100	2.205
02:02 ET	271	2.2082
02:04 ET	900	2.195
02:09 ET	500	2.195
02:11 ET	775	2.1902
02:22 ET	2829	2.1895

Data delayed at least 15 minutes.

Today
- Cardiol Therapeutics Achieves Target Patient Enrollment in its Phase II ARCHER Trial Investigating CardiolRx(TM) for Acute Myocarditis, from 7 hours ago by Dow Jones
  7 hours ago by Dow Jones
Sep 10, 2024
- Cardiol Therapeutics Announces Completion of the MAvERIC Phase II Study in Recurrent Pericarditis with Results to be Presented at the American Heart Association Scientific Sessions 2024, from 7:29AM ET on Tuesday Sep 10, 2024 by Dow Jones
  7:29AM ET on Tuesday Sep 10, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesCRDL Cardiol Therapeutics Inc	217.6M	0.0x	---
As of 2024-09-24

Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. It is also developing CRD-38, a novel subcutaneously administered drug intended for use in heart failure. It has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart.

Contact Information

Headquarters: 602-2265 Upper Middle Road EastOAKVILLE, ON, Canada L6H 0G5
Phone: 289-910-0850
Fax: 905-491-6793

Executives

No data available

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$217.6M
Revenue (TTM)	$0.00
Shares Outstanding	69.9M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	0.72
EPS	$-0.44
Book Value	$0.43
P/E Ratio	0.0x
Price/Sales (TTM)	---
Price/Cash Flow (TTM)	---
Operating Margin	---

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Cardiol Therapeutics Inc
NASDAQ:CRDLUnited StatesView on Canadian Exchange

Search Criteria

Charts

Recent News

Today

Cardiol Therapeutics Achieves Target Patient Enrollment in its Phase II ARCHER Trial Investigating CardiolRx(TM) for Acute Myocarditis, from 7 hours ago by Dow Jones

Sep 10, 2024

Cardiol Therapeutics Announces Completion of the MAvERIC Phase II Study in Recurrent Pericarditis with Results to be Presented at the American Heart Association Scientific Sessions 2024, from 7:29AM ET on Tuesday Sep 10, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar